Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

WANG Jing, ZHANG Chuan, LI Yi, REN Jinmei, TANG Kouming. Determination of palmitul 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate liposome by HPLC method[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(5): 450-452,480. doi: 10.3969/j.issn.1006-0111.2019.05.012
Citation: WANG Jing, ZHANG Chuan, LI Yi, REN Jinmei, TANG Kouming. Determination of palmitul 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate liposome by HPLC method[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(5): 450-452,480. doi: 10.3969/j.issn.1006-0111.2019.05.012

Determination of palmitul 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate liposome by HPLC method

doi: 10.3969/j.issn.1006-0111.2019.05.012
  • Received Date: 2019-02-14
  • Rev Recd Date: 2019-05-06
  • Objective To establish a HPLC method for the assay of palmitul 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate (PDSS) in liposomes. Methods The separation was performed with an Agilent ZORBAX Eclipse Plus C18 column (4.6 mm×200 mm,5 μm) at room temperature.The mobile phase was acetonitrile-aqueous solution (500 ml water + 0.1 ml triethylamine + 0.1 ml formic acid,pH=6-7) (50:50) with the flow rate of 1 ml/min.Zidovudine palmitate was detected at 280 nm. Results PDSS had a good linear recovery between 0.05-0.45 mg/ml.The intra-day and inter-day RSD were <2%.The extracted recovery was in the range of 96% to 102%.The assay results for three batches were 97.81%,101.20% and 98.53%. Conclusion This method is simple,accurate and reliable.It can be used for the determination of PDSS in liposomes.
  • [1] 陈伟伟,高润霖,刘力生,等.中国心血管病报告2016(概要)[J].中国循环杂志,2017,32(6):521-530.
    [2] ZHOU L M,ZUO Z,CHOW M S S.Danshen:an overview of its chemistry,pharmacology,pharmacokinetics,and clinical use[J].J Clin Pharmacol,2005,45(12):1345-1359.
    [3] WU L,QIAO H,LI Y,et al.Protective roles of puerarin and Danshensu on acute ischemic myocardial injury in rats[J].Phytomedicine,2007,14(10):652-658.
    [4] YIN Y,GUAN Y,DUAN J L,et al.Cardioprotective effect of Danshensu against myocardial ischemia/reperfusion injury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1/2 phosphorylation[J].Eur J Pharmacol,2013,699(1-3):219-226.
    [5] LAM F F,YEUNG J H,CHAN K M,et al.Relaxant effects of danshen aqueous extract and its constituent Danshensu on rat coronary artery are mediated by inhibition of calcium channels[J].Vascul Pharmacol,2007,46(4):271-277.
    [6] TANG Y Q,WANG M H,LE X Y,et al.Antioxidant and cardioprotective effects of Danshensu (3-(3,4-dihydroxyphenyl)-2-hydroxy-propanoic acid from Salvia miltiorrhiza) on isoproterenol-induced myocardial hypertrophy in rats[J].Phytomedicine,2011,18(12):1024-1030.
    [7] LE X Y.Effects of danshensu on the incidence of ischemia-reperfusion induced arrhythmia in hypertrophy rat heart[J].Chin J Nat Med,2009,6(6):461-465.
    [8] WANG F,LIU Y Y,LIU L Y,et al.The attenuation effect of 3,4-dihydroxy-phenyl lactic acid and salvianolic acid B on venular thrombosis induced in rat mesentery by photochemical reaction[J].Clin Hemorheol Microcirc,2009,42(1):7- 18.
    [9] TANG Y Q,WANG M H,CHEN C L,et al.Cardiovascular protection with Danshensu in spontaneously hypertensive rats[J].Biol Pharm Bull,2011,34(10):1596-1601.
    [10] LIU D,HU H Y,LIN Z X,et al.Quercetin deformable liposome:Preparation and efficacy against ultraviolet B induced skin damages in vitro and in vivo[J].J Photochem Photobiol B:Biol,2013,127:8-17.
    [11] SLINGERLAND M,GUCHELAAR H J,GELDERBLOM H.Liposomal drug formulations in cancer therapy:15 years along the road[J].Drug Discov Today,2012,17(3-4):160-166.
    [12] 纪周新,刘琳琳,李艺养,等.丹参素脂质体的制备及体外释放度研究[J].中国药师,2015,18(10):1649-1651,1660.
    [13] GUO X J,FAN X J,QIAO B,et al.A lipophilic prodrug of Danshensu:preparation,characterization,and in vitro and in vivo evaluation[J].Chin J Nat Med,2017,15(5):355-362.
  • 加载中
通讯作者: 陈斌, [email protected]
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(3126) PDF downloads(415) Cited by()

Related
Proportional views

Determination of palmitul 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate liposome by HPLC method

doi: 10.3969/j.issn.1006-0111.2019.05.012

Abstract: Objective To establish a HPLC method for the assay of palmitul 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate (PDSS) in liposomes. Methods The separation was performed with an Agilent ZORBAX Eclipse Plus C18 column (4.6 mm×200 mm,5 μm) at room temperature.The mobile phase was acetonitrile-aqueous solution (500 ml water + 0.1 ml triethylamine + 0.1 ml formic acid,pH=6-7) (50:50) with the flow rate of 1 ml/min.Zidovudine palmitate was detected at 280 nm. Results PDSS had a good linear recovery between 0.05-0.45 mg/ml.The intra-day and inter-day RSD were <2%.The extracted recovery was in the range of 96% to 102%.The assay results for three batches were 97.81%,101.20% and 98.53%. Conclusion This method is simple,accurate and reliable.It can be used for the determination of PDSS in liposomes.

WANG Jing, ZHANG Chuan, LI Yi, REN Jinmei, TANG Kouming. Determination of palmitul 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate liposome by HPLC method[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(5): 450-452,480. doi: 10.3969/j.issn.1006-0111.2019.05.012
Citation: WANG Jing, ZHANG Chuan, LI Yi, REN Jinmei, TANG Kouming. Determination of palmitul 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate liposome by HPLC method[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(5): 450-452,480. doi: 10.3969/j.issn.1006-0111.2019.05.012
Reference (13)

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return